ZhuZhou QianJin Pharmaceutical Co.,Ltd

符号: 600479.SS

SHH

10.91

CNY

今天的市场价格

17.9517
市盈率
0.4616
PEG比率
4.56B
MRK市值
0.03%
DIV收益率

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) 财务报表

Q: 什么是 ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) 总资产是多少？

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS). 的默认数据。公司收入显示 1936.44 M 的平均值，即 0.077 % 增长率。整个期间的平均毛利润为 886.049 M，即 0.137 %. 平均毛利率为 0.450 %. 公司去年的净收入增长率为 0.059 %，等于 0.123 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 ZhuZhou QianJin Pharmaceutical Co.,Ltd 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.012. 在流动资产领域，600479.SS 的报告货币为3514.486. 这些资产中的很大一部分，即 1997.9 是现金和短期投资。与去年的数据相比，该部分的变化率为0.154%. 公司的长期投资虽然不是其重点，但以报告货币计算的293.273（如果有的话）为293.273。这表明与上一报告期相比，-196.424% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 38.463. 这一数字表明，-0.061% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 2389.672. 这方面的年同比变化率为 0.078%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为967.023，存货估值为 534.14，商誉估值为 14.07（如有. 无形资产总额（如果有）按 238.27 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
balance-sheet.row.cash-and-short-term-investments	6888.47	1997.9	1731.7	1369.7	1407.6	1378	1100.2	690.3	736.2	544.3	297	205.3	243.2	217.7	334.9	416.9	507.4	527.4	435.8	410.4	383.6	71.3	72.9	93.4
balance-sheet.row.short-term-investments	-97.51	-45.7	491.7	736.8	652.3	-39.6	109.1	182.2	7.8	31.1	69.6	22.1	92.5	98.5	60.3	232	0.2	130	35	6	6.1	0	0	0.2
balance-sheet.row.net-receivables	4356.41	967	983.9	921.6	1164.8	1078.8	972.4	1043	951.2	843.5	876.3	743	610.6	558.1	307.8	260.4	196.8	105.9	113.7	143.4	160.4	113.9	82.8	97.7
balance-sheet.row.inventory	2227.63	534.1	599	547.8	496.8	469.5	440.9	376.3	358.5	272.3	243.2	222.5	195.3	117	126.5	98.8	96.5	82.9	87.3	75.1	84.1	84.9	71	77.5
balance-sheet.row.other-current-assets	281.2	15.4	198.9	78.1	120.2	29	82.9	319.7	87.2	267.7	27	5.6	6.7	-29.7	-12.6	-9.8	-12.1	-4.2	-7.1	-8.7	-13.2	-11.6	-13.5	-19.4
balance-sheet.row.total-current-assets	13753.71	3514.5	3513.5	2917.3	3189.3	2955.3	2596.3	2429.2	2133	1927.8	1443.6	1176.4	1055.8	863.1	756.5	766.3	788.6	711.9	629.7	620.1	614.8	258.5	213.1	249.1
balance-sheet.row.property-plant-equipment-net	2371.59	589.9	622.8	630.2	491	478.7	499.8	529.2	565.4	491.4	415.2	396.8	334.6	309.8	285.4	286.7	193.2	153.4	154.6	160	163	150.2	134.7	77.3
balance-sheet.row.goodwill	56.3	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	8.7	8.7	8.7	8.7	8.7	8.7	0	0	0	0	0	0
balance-sheet.row.intangible-assets	906.1	238.3	221.8	219.6	216.4	255.2	285.8	241.2	259.8	260.4	247.3	252.8	199.5	45.3	46.5	47.7	47.1	20.2	20.2	4.4	4.6	4.6	4.5	4.6
balance-sheet.row.goodwill-and-intangible-assets	962.39	252.3	235.9	233.7	230.5	269.3	299.9	255.3	273.9	274.5	261.4	266.9	208.2	54	55.2	56.5	55.8	28.9	20.2	4.4	4.6	4.6	4.5	4.6
balance-sheet.row.long-term-investments	965.47	293.3	-304.1	-546.1	-462	103	-63.7	-136.8	37.6	4.3	-33.2	14.2	-57.2	-57	-40.5	-86.9	13.4	54	-16.4	3.9	0.5	0	0	0.4
balance-sheet.row.tax-assets	68.79	22.7	6.6	4.1	4.2	4.2	4.6	6.9	4	3.4	2.5	2.7	1.3	2.1	0.9	0.5	0.5	1.4	0	0	0	0	0	1.3
balance-sheet.row.other-non-current-assets	141.8	4.2	547.3	821	775.7	1.7	135.7	203	18.2	41.9	139.5	31.2	102.4	109.7	71	242.8	7.9	135.6	40.7	9.8	9.7	7.9	7.6	0
balance-sheet.row.total-non-current-assets	4510.04	1162.4	1108.5	1143	1039.4	856.9	876.2	857.6	899.1	815.4	785.4	711.9	589.4	418.6	371.9	499.5	270.8	373.3	199	178.1	177.7	162.8	146.8	83.6
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	18263.75	4676.9	4622	4060.2	4228.7	3812.2	3472.5	3286.9	3032.1	2743.2	2228.9	1888.3	1645.2	1281.7	1128.5	1265.8	1059.4	1085.3	828.7	798.2	792.5	421.3	359.9	332.8
balance-sheet.row.account-payables	2617.36	647.5	780.9	511.7	623	529.1	485.8	469.5	446	317	369.4	168.9	86.1	80.2	80.7	109	91.7	82	81	56.1	69.5	74.6	49.1	77.3
balance-sheet.row.short-term-debt	279.3	78.2	79.5	88.6	135.9	1.9	1	1	0.5	3.1	61	87	115.9	0	0	131	0	0	0	0	12	33.1	32.8	1.5
balance-sheet.row.tax-payables	218.03	70.6	72.5	35.6	45.2	41	61.3	67.5	32.9	23.1	41.6	28.4	28.4	34.3	10	15.2	26.6	23.7	23.2	11.3	11.6	18.9	17.1	12.9
balance-sheet.row.long-term-debt-total	144.84	38.5	44.8	60.3	19.5	20.5	26.7	37.3	47.3	54	32	5.2	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	8.7
Deferred Revenue Non Current	155.79	38	44.4	51.3	51.8	42.8	44.4	51.5	50.2	52.9	41.6	44.5	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	78.35	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	280.05	69.1	705.6	75.5	84.9	192.3	407.8	130.1	165.4	149.6	125	97.9	76.8	181.3	81.5	19.5	89.4	83.6	85.5	144.7	1.9	5.5	1.6	0.7
balance-sheet.row.total-non-current-liabilities	407.36	108.3	108.5	131.9	89	81.5	86.6	111.3	111.2	117.6	84.3	55.3	30	26.6	26.5	2.6	2.6	23.7	2.6	2.6	3	3.4	3.4	11.5
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	110.84	31.5	32.8	44.8	42.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	6493.32	1650.1	1805.7	1360.3	1466.7	1182.6	1042.5	1045.7	948.2	779.2	843.2	683.9	581.2	288.1	188.6	314.5	183.7	189.3	169.1	203.4	148.4	188.2	174.3	182.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1716.69	428.9	429.8	418.5	418.5	418.5	418.5	348.8	348.8	348.8	304.8	304.8	304.8	304.8	304.8	217.7	181.4	151.2	126	84	56	38	38	38
balance-sheet.row.retained-earnings	4286.33	1142.5	970.8	930.7	1047.2	959.4	826.1	694.2	568.4	481.4	456.1	414.1	377.7	328.3	328.2	356.9	295.8	260.5	115.5	60.7	122.1	114.1	71.9	57.3
balance-sheet.row.accumulated-other-comprehensive-income-loss	2362.59	280.8	275.3	298.1	298.1	297.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	933.42	537.5	540.3	503	503	503	784.2	834.4	828.5	816.7	360.6	289.3	283.5	275.2	268.6	349.4	374.2	463	399	433.8	452.5	64.8	56	40.1
balance-sheet.row.total-stockholders-equity	9299.03	2389.7	2216.2	2150.4	2266.8	2178.1	2028.8	1877.4	1745.7	1646.8	1121.5	1008.2	966	908.3	901.6	924	851.4	874.6	640.6	578.5	630.6	216.9	165.8	135.4
balance-sheet.row.total-liabilities-and-stockholders-equity	18263.75	4676.9	4622	4060.2	4228.7	3812.2	3472.5	3286.9	3032.1	2743.2	2228.9	1888.3	1645.2	1281.7	1128.5	1265.8	1059.4	1085.3	828.7	798.2	792.5	421.3	359.9	332.8
balance-sheet.row.minority-interest	2471.4	637.1	600.1	549.5	495.2	451.5	401.1	363.8	338.2	317.2	264.3	196.2	98	85.3	38.2	27.3	24.3	21.3	19	16.4	13.5	16.1	19.7	14.5
balance-sheet.row.total-equity	11770.43	3026.8	2816.3	2699.9	2762	2629.6	2430	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	18263.75	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	867.96	247.6	187.6	190.8	190.3	63.4	45.3	45.3	45.3	35.3	36.3	36.3	35.3	41.6	19.8	145.1	13.6	184	18.6	10	6.5	6.5	5.5	0.5
balance-sheet.row.total-debt	424.14	116.7	124.2	148.9	155.4	22.4	27.7	38.3	47.8	57.1	93	87	115.9	0.7	0.7	131	0.7	0.7	0.7	0.7	12	33.1	32.8	1.5
balance-sheet.row.net-debt	-6414.01	-1881.2	-1115.7	-484	-600	-1355.5	-963.4	-469.8	-680.6	-456.1	-134.4	-96.2	-34.8	-118.5	-274	-53.9	-506.6	-396.7	-400.1	-403.7	-365.5	-38.2	-40.1	-91.7

现金流量表

在 ZhuZhou QianJin Pharmaceutical Co.,Ltd 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.429 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了-0.207 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到585285163.000. 与上一年相比， 3.792 发生了变化. 在同一时期，公司记录了 103.65, 0.06 和 -50.72，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-147.89 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -13.06，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
cash-flows.row.net-income	278.61	395	388.3	374.7	360.2	352.1	302.6	246.7	173.4	88.3	117.7	128.8	130.9	94.8	97.6	136.9	134.5	176.6	75	61.7	46.6	48.4	38.9
cash-flows.row.depreciation-and-amortization	14.07	103.7	95.6	85.9	60.9	61.1	61.8	62.7	50.2	50.4	48.5	48.3	40	38.3	36	25.2	21.8	20.9	24.3	23.3	22	18.3	13.1
cash-flows.row.deferred-income-tax	-73.79	-2.8	-3.6	2.7	1.4	-0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	18.19	2.8	3.6	-2.7	-1.4	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	53.6	-81.7	246.9	65.8	129.5	-233	29.3	-11.8	-81.8	-73.8	15.1	-49.5	40.4	-122.7	-81.4	-68.9	-88.6	2.4	47.2	-1.1	-46.4	-19.4	-45.6
cash-flows.row.account-receivables	-8.69	-8.7	-163.7	275.9	27.2	-362.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	62.29	62.3	-51.2	-52.4	-27.3	-29.1	-64.7	-17.9	-85.5	-29.9	-22.4	-19.8	-78.4	9.6	-27.7	-2	-13.2	3.7	1.7	8.3	1	-13.8	3.1
cash-flows.row.account-payables	0	-132.5	465.4	-160.4	128.2	159.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-2.8	-3.6	2.7	1.4	-0.9	94	6.1	3.8	-44	37.4	-29.6	118.8	-132.3	-53.7	-66.8	-75.4	-1.3	45.5	-9.4	-47.4	-5.6	-48.7
cash-flows.row.other-non-cash-items	191.12	26.1	2.7	-40.9	-8.2	-24.7	-10.2	-14.1	-0.9	2.6	2.1	10.1	-13.6	12.2	-13	-19.7	-30.4	-120.6	-26.3	-7.5	-3.8	3.6	-0.3
cash-flows.row.net-cash-provided-by-operating-activities	474.21	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-36.4	-44	-34.4	-71.9	-97.2	-40.6	-46.4	-57.3	-81.5	-84.5	-66	-84.3	-256.3	-63.9	-58.4	-123.3	-95.3	-22.5	-21.4	-16.7	-56.5	-34	-59.2
cash-flows.row.acquisitions-net	0.06	0	0.2	30.8	103.6	73	0	13	0.7	85	1.2	-21.4	0.6	1.3	5.8	0.8	0.3	0.8	2.1	0.6	1	0.1	0.2
cash-flows.row.purchases-of-investments	-100.06	-402	-2102	-1570	-2641	-285	-904	-1403.9	-1001.7	-769.6	-405	-135.1	-235.4	-891.1	-565.5	-1545.8	-1482	-576.3	-855.2	-1103.4	-225.3	-1	-5
cash-flows.row.sales-maturities-of-investments	357.66	1031.2	2258.4	1567.7	1770.3	469.5	1222.9	1006.1	1197.1	605.1	357.6	207.4	266.3	820.6	889.9	1194	1728.4	549.6	845.8	1107.5	219.4	0.5	0.3
cash-flows.row.other-investing-activites	75.41	0.1	0	0	-97.2	-40.6	2.5	24.3	5.9	-84.5	0.4	0.1	0	-3.9	1.6	2.8	2.8	3.1	2.4	1.8	3.7	2	1.6
cash-flows.row.net-cash-used-for-investing-activites	221.32	585.3	122.1	-43.3	-961.5	176.3	275	-417.8	120.6	-248.5	-111.8	-33.3	-224.7	-137	273.3	-471.5	154.1	-45.3	-26.3	-10.3	-57.8	-32.5	-62.2
cash-flows.row.debt-repayment	-50.72	-50.7	-15	-127.6	-19.1	-6.2	-10.6	-9.5	-9.3	-105	-147	-180.9	-7.5	-20	-605	-4937	0	-550	-700	-12	-333.7	-39.7	-15.3
cash-flows.row.common-stock-issued	1.41	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-3.38	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-165.13	-147.9	-248.6	-429.5	-209.3	-167.1	-105	-71.4	-54.4	-66.7	-60.7	-79.9	-61.3	-76.2	-108.9	-59.5	-79.6	-36.4	-96	-28.2	-32.1	-22	-7.7
cash-flows.row.other-financing-activites	-17.62	-13.1	-0.5	36.5	124.2	-7.4	-9.1	-12.7	-1.2	620	154.9	180.8	125	55.2	497.8	5065.6	-1.9	548.9	698.6	0.9	711.3	41.7	58.8
cash-flows.row.net-cash-used-provided-by-financing-activities	-219.51	-202	-264.2	-520.6	-104.2	-180.7	-124.7	-93.6	-65	448.4	-52.8	-80	56.2	-41.1	-216.1	69.1	-81.5	-37.4	-97.3	-39.3	345.5	-20	35.8
cash-flows.row.effect-of-forex-changes-on-cash	-8.88	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	467.14	826.4	591.4	-78.3	-523.4	151.1	533.7	-227.9	196.4	267.4	18.8	24.3	29.3	-155.4	96.3	-328.9	109.9	-3.4	-3.6	26.9	306.2	-1.5	-20.3
cash-flows.row.cash-at-end-of-period	6497.52	1928.3	1101.9	510.5	588.8	1112.3	961.2	427.4	655.4	458.9	191.5	172.8	148.5	119.2	274.6	178.4	507.2	397.4	400.8	404.3	377.5	71.3	72.9
cash-flows.row.cash-at-beginning-of-period	6030.38	1101.9	510.5	588.8	1112.3	961.2	427.4	655.4	458.9	191.5	172.8	148.5	119.2	274.6	178.4	507.2	397.4	400.8	404.3	377.5	71.3	72.9	93.2
cash-flows.row.operating-cash-flow	474.21	443.1	733.5	485.6	542.4	155.5	383.5	283.5	140.9	67.5	183.3	137.6	197.8	22.6	39.1	73.5	37.2	79.3	120.1	76.5	18.5	51	6.1
cash-flows.row.capital-expenditure	-36.4	-44	-34.4	-71.9	-97.2	-40.6	-46.4	-57.3	-81.5	-84.5	-66	-84.3	-256.3	-63.9	-58.4	-123.3	-95.3	-22.5	-21.4	-16.7	-56.5	-34	-59.2
cash-flows.row.free-cash-flow	437.81	399.1	699	413.7	445.1	114.9	337.1	226.2	59.4	-17	117.4	53.4	-58.4	-41.3	-19.3	-49.8	-58.1	56.7	98.7	59.8	-38	16.9	-53.2

利润表行

ZhuZhou QianJin Pharmaceutical Co.,Ltd 的收入与上期相比变化了 -0.057%。据报告, 600479.SS 的毛利润为 1751.76。该公司的营业费用为 3337.92，与上年相比变化了 154.481%. 折旧和摊销费用为 103.65，与上一会计期间相比变化了 -0.005%. 营业费用报告为 3337.92，显示154.481% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.037%. 营业收入为 460.57，与上年相比变化了0.037%. 净利润的变化率为 0.059%。去年的净收入为320.41.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
income-statement-row.row.total-revenue	3839.03	3798.5	4026.3	3663.8	3627	3525.2	3328.6	3182.7	2864.9	2446.7	2194.2	1972.9	1583.4	1256.5	979.4	904.3	801.4	679.8	602.7	665.8	604.9	686.8	582	560.2
income-statement-row.row.cost-of-revenue	2054.9	2046.7	2289.9	2032.2	2030.8	1918.7	1776.3	1743.2	1573.3	1311.5	1141.1	1006.8	786.3	603.5	427.9	360.8	345.8	322.3	309.4	423.8	409.4	476.1	405.9	417.3
income-statement-row.row.gross-profit	1784.14	1751.8	1736.4	1631.6	1596.2	1606.5	1552.3	1439.5	1291.6	1135.2	1053.1	966	797.1	653	551.6	543.4	455.6	357.5	293.3	242	195.5	210.7	176.1	142.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	185.64	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	68.58	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	884.41	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-840.99	-3337.9	218.6	189.1	156.1	147.8	14.9	-9.7	13.6	15	10.5	3.7	0.7	1.6	8.1	1.7	-1.1	0.1	1.2	1.3	1.8	-0.8	-0.9	-2
income-statement-row.row.operating-expenses	1892.94	3337.9	1311.7	1261.1	1224.8	1247.8	1249.1	1170.9	1111.7	1042.9	924.3	810.4	663.7	536.5	474	404.5	345.3	282.9	237.7	178	146.3	142.3	118.1	92.9
income-statement-row.row.cost-and-expenses	3399.17	3337.9	3601.5	3293.4	3255.6	3166.5	3025.4	2914.1	2685	2354.4	2065.4	1817.2	1450	1140.1	901.8	765.3	691	605.2	547.1	601.8	555.7	618.4	524	510.1
income-statement-row.row.interest-income	48.46	51.4	9.8	11.9	30.4	38.6	20.9	11.7	10.9	4.6	1.2	0.2	1.7	4.1	1.6	0	0	0	2.4	1.8	3.7	1.9	1.6	1.7
income-statement-row.row.interest-expense	1.26	1.7	2.2	2.1	2.2	0.4	0.7	2.6	2.8	6.5	6.1	4.1	2.1	0.2	0.1	-1	-1.9	0.7	1.1	0.1	1.2	2.3	1.1	0.3
income-statement-row.row.selling-and-marketing-expenses	884.41	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-1.23	-1.5	1.6	-2.8	0.4	-1.1	49.1	18	26.5	17.3	11.6	-2.8	17.9	-6.8	31.9	17.1	31.4	123.3	27.9	9.1	6.5	1.2	1.3	-0.5
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-840.99	-3337.9	218.6	189.1	156.1	147.8	14.9	-9.7	13.6	15	10.5	3.7	0.7	1.6	8.1	1.7	-1.1	0.1	1.2	1.3	1.8	-0.8	-0.9	-2
income-statement-row.row.total-operating-expenses	-1.23	-1.5	1.6	-2.8	0.4	-1.1	49.1	18	26.5	17.3	11.6	-2.8	17.9	-6.8	31.9	17.1	31.4	123.3	27.9	9.1	6.5	1.2	1.3	-0.5
income-statement-row.row.interest-expense	1.26	1.7	2.2	2.1	2.2	0.4	0.7	2.6	2.8	6.5	6.1	4.1	2.1	0.2	0.1	-1	-1.9	0.7	1.1	0.1	1.2	2.3	1.1	0.3
income-statement-row.row.depreciation-and-amortization	-79.84	103.7	104.2	47.3	60.3	40.8	61.8	62.7	50.2	50.4	48.5	48.3	40	38.3	36	25.2	21.8	20.9	24.3	23.3	22	18.3	13.1	-1.9
income-statement-row.row.ebitda-caps	486.32	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	465.79	460.6	444.2	436.2	424.2	430.8	337.4	296.3	194	94.8	130.4	150	150.9	108.1	101.5	155.2	143.1	198.9	83.9	74.3	55.3	71.5	60.2	51.9
income-statement-row.row.income-before-tax	464.56	459.1	445.8	433.4	424.6	429.7	352.3	286.6	206.4	109.6	140.4	152.8	151.3	109.7	109.5	156.1	141.8	197.9	84.3	74.3	56.4	70.1	59.3	49.7
income-statement-row.row.income-tax-expense	66.62	65.4	57.6	58.7	64.4	77.6	49.7	40	33	21.3	22.7	24.1	20.4	14.9	12	19.1	7.3	21.3	9.4	12.6	9.8	21.7	20.3	14.4
income-statement-row.row.net-income	278.61	320.4	302.5	302.1	297.1	294.3	255.4	207.8	149.4	93	105.1	123.8	120.2	82.8	86.4	130.9	129.9	173.6	71.8	59.9	45.4	50.1	39.8	34.5